RMND1 and breast carcinoma: In the estrogen receptor negative subtype of breast cancer, RMND1 expression is reduced in tumor samples associated with minor risk alleles but increased in those with major risk alleles, suggesting its possible dual role in breast cancer pathogenesis [178].